Robles-Espinosa LA, García-Escamilla RM, Valencia-Sánchez S

Language: Spanish
References: 21
Page: 78-83
PDF size: 81.10 Kb.

ABSTRACT

Introduction: The atrial fibrillation is a very common cardiac rhythm disorder in medical practice. The patients that suffer this disease show disturbance in coagulation system, specially antithrombin III and fibrinogen levels. Objective: To determine the correlation between echocardiographic image, antithrombin III and fibrinogen levels in patients with atrial fibrillation. Methodology: The transesophagic echocardiogram, antithrombin III and fibrinogen levels were determined in 47 patients with atrial fibrillation, that were admitted in Emergency Service of Cardiology Hospital of Medical Center XXI Century. Results: For statistics analysis for association; Student t and χ square were p‹0.05 in analysis of correlation Spearman and Pearson without correlation statistics between echocardiography and antithrombin III and fibrinogen levels. In the group of patients of less than 65 years old, 30 (63.8 %) were observed; these 4 (8.5 %) showed antithrombin III low and thrombi. In the group of more than 65 years old, there were 17 patients (36.2 %), these 3 (6.4 %) with antithrombin III low and thrombi, and 4 (8.5 %) with antithrombin III normal and thrombi. It was found that the hematocrit increased in this group formed by 5 males and 12 females. Conclusions: The antithrombin III (88-131 %) and fibrinogen (200-400 mg/dL) do not have a statistic correlation between echocardiographics and atrial fibrillation. The low levels of antithrombin III do not have correlation between spontaneous contrast and hematocrit increase thrombosis. The increase of fibrinogen and hematocrit predominated in women.

REFERENCES

1. Prystowsky E, Benson D, Fuster V, Hart R. Management of patients with atrial fibrillation. Circulation 1996;93:1262-1277.

2. Fatkin D, Fenely M. Stratification of thromboembolic risk of atrial fibrillation by transthoracic echocardiography and transesophageal echocardiography, the relative role of left atrial appendage function mitral disease and spontaneous echocardiographics contrast. Prog Cardiovasc Dis 1996;39:57-58.

3. Stoodart M, Dawkins P. Left atrial appendage thrombosis is not uncommon in patients with acute atrial fibrillation and recent embolic event: a transesophageal echocardiography study. JACC 1995;25:422-459.

4. Macktaller L. Alpert J. Atrial fibrillation a review of mechanism, etiology and therapy. Clin Cardiol 1997;20:640-650.

5. Omram H, Jung W, Rabahem R. Left atrial chamber and appendage function after internal atrial desfibrillation, a prospective and serial transesophageal echocardiographic study. JACC 1997;29:131-138.

6. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Circulation 1991;84:527-539.

7. Carlson J, Tbbe U, Rox J. Cardiovertion of atrial fibrillation in the elderly. Am J Cardiol 1996;78:1380-1384.

8. Laragh JH, Sonneblink EH, Alderman MH, Mura M. Atrial fibrillation and stroke prevention: a symposium cardiovascular review. Eur Heart J 1997;18:11-27.

9. Ponfratz G, Brandt M, Henneke KH, Zink D, Gehling G. Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation. Chest 1997;111:929-933.

10. García MA, Torrecilla SG, Sanroman D, Acevedo J, Bueno H, Moreno M. Left atrial appendage Doppler flow patterns: Implications on thrombus formation. Am Heart J 1992;124:955-960.

11. Leung DY, Grim RA, Lein AL. Transesophageal echocardiography-quided approach to cardiovertion an fibrillation. Prog Cardiovasc Dis 1996;39:21-32.

12. Seto TB, Taira DA, Tsevat J, Manning WJ. Cost-effectiveness of transesophageal echocardiography-quided cardiovertion, a decision analytic model for patients admitted to the hospital with atrial fibrillation. JACC 1997;29:122-130.

13. Levy S, Breithard G, Campbell WF, Camm AJ. Atrial fibrillation current knowledge and recommendations for management. Eur Heart J 1998;19:1294-1320.

14. Sohara H, Kuruse S, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxymal atrial fibrillation. JACC 1997;29:106-112.

15. Stoodard MF. Risk of thromboembolism in new onset or transient atrial fibrillation. Prog Cardiovasc Dis 1996;1:69-80.

16. Black IW, Chesterman CN, Hopkins AP, Lee LCL, Chong BH. Hematological correlates of atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. JACC 1993;21: 451-457.

17. Gregory YH, Zarafis J, Robert DS, Gordon DB, Beebers G. Fibrin, D-dimer and beta-thromboglubulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Circulation 1996;94:425-431.

18. Ernes E, Ludwin K. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Inter Med 1993;118: 956-963.

19. Qizilbash N. Fibrinogen and cerebrovascular disease. Eur Heart J 1995;16:42-26.

20. Faltkin D, Herbert E, Feneley MP. Hematological correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol 1994;73:672-676.

21. Wang XF, Tsung LL, Li Z, Deng YB, Wang JE. The relationship between intracardiovascular smoke-like echo and erythrocyte Rouleaux formation. Am Heart J 1992;4:961-965.